Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions

Prospective identification of tumorigenic breast cancer cells

Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,388 · see citing works

The basics of epithelial-mesenchymal transition

Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · see citing works

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,679 · see citing works

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · see citing works

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action

Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · see citing works

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M. T., Cronin, W. M., Vogel, V. G., Robidoux, A., Dimitrov, N. S., Atkins, J. N., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,478 · see citing works

The retinoblastoma protein and cell cycle control

Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · see citing works

Cancer genes and the pathways they control

Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,245 · see citing works

TGFβ in Cancer

Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907 · see citing works

Induction of autophagy and inhibition of tumorigenesis by beclin 1

Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347 · see citing works

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · see citing works

Drug repositioning: identifying and developing new uses for existing drugs

Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237 · see citing works

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · see citing works

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · see citing works

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint

Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413 · see citing works

Metformin and reduced risk of cancer in diabetic patients

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · see citing works

Insulin and insulin-like growth factor signalling in neoplasia

Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · see citing works

Four faces of cellular senescence

Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,016 · cited 1× · see citing works

let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,906 · see citing works

Role of autophagy in cancer

Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798 · see citing works

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

Li, X., Lewis, M. T., Huang, J., Gutiérrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A. C., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,789 · see citing works

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

Morel, A., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,673 · see citing works

Inhibition of Macroautophagy Triggers Apoptosis

Boya, P., González‐Polo, R. A., Casares, N., Perfettini, J., Dessen, P., Larochette, N., Métivier, D., Meley, D., Souquère, S., Yoshimori, T., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1025-1040.2005 · Cited by 1,629 · see citing works

SREBP transcription factors: master regulators of lipid homeostasis

Eberlé, D., Hegarty, B. D., Bossard, P., Ferré, P., & Foufelle, F. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.018 · Cited by 1,531 · see citing works

Senescence-associated β-galactosidase is lysosomal β-galactosidase.

Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444 · see citing works

Direct regulation of TWIST by HIF-1α promotes metastasis

Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345 · see citing works

Lysosomes and autophagy in cell death control

Kroemer, G., & Jäättelä, M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1738 · Cited by 1,291 · see citing works

Senescence in tumours: evidence from mice and humans

Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 19× · see citing works

Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission

Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115 · see citing works

Diabetes and Cancer: A Consensus Report

Giovannucci, E. L., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,065 · see citing works

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048 · see citing works

Potential therapeutic applications of autophagy

Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 1,004 · see citing works

Cellular mechanisms of tumour suppression by the retinoblastoma gene

Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974 · see citing works

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933 · see citing works

Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth

Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923 · see citing works

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 2× · see citing works

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861 · see citing works

Autophagy in metazoans: cell survival in the land of plenty

Lum, J., DeBerardinis, R., & Thompson, C. (2005) · Nature reviews. Molecular cell biology · doi:10.1038/nrm1660 · Cited by 842 · see citing works

Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesisPreprint

Karantza‐Wadsworth, V., Patel, S. A., Kravchuk, O., Chen, G., Mathew, R., Jin, S., & White, E. (2007) · Genes & Development · doi:10.1101/gad.1565707 · Cited by 841 · see citing works

The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?

Brabletz, S., & Brabletz, T. (2010) · EMBO Reports · doi:10.1038/embor.2010.117 · Cited by 793 · see citing works

A microenvironmental model of carcinogenesis

Gatenby, R. A., & Gillies, R. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2255 · Cited by 725 · see citing works

Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence

Ansieau, S., Bastid, J., Doreau, A., Morel, A., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.005 · Cited by 713 · see citing works

Normal Stem Cells and Cancer Stem Cells: The Niche Matters

Li, L., & Neaves, W. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3986 · Cited by 675 · see citing works

The role of let-7 in cell differentiation and cancer

Boyerinas, B., Park, S.-M., Hau, A., Murmann, A. E., & Peter, M. E. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0184 · Cited by 671 · see citing works

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

Yang, M., Hsu, D. S., Wang, H., Wang, H.-J., Lan, H., Yang, W., Huang, C.-H., Kao, S., Tzeng, C., Tai, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2099 · Cited by 631 · see citing works

Untitled work

(2003) · PubMed · Cited by 608 · see citing works

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study

Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607 · see citing works

IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro

Bendall, S. C., Stewart, M. H., Menéndez, P. R., George, D., Vijayaragavan, K., Werbowetski‐Ogilvie, T. E., Ramos–Mejía, V., Rouleau, A., Yang, J., Bosse, M. M., et al. (2007) · Nature · doi:10.1038/nature06027 · Cited by 588 · see citing works

ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

Muthuswamy, S. K., Li, D., Lelièvre, S. A., Bissell, M. J., & Brugge, J. S. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-785 · Cited by 554 · see citing works

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Honeth, G., Bendahl, P., Ringnér, M., Saal, L. H., Gruvberger-Saal, S. K., Lövgren, K., Grabau, D. A., Fernö, M., Borg, Å., & Hegardt, C. (2008) · Breast Cancer Research · doi:10.1186/bcr2108 · Cited by 553 · see citing works

Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells

Sahra, I. B., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., Gounon, P., MARCHAND‐BRUSTEL, Y. L., Giorgetti‐Peraldi, S., Cormont, M., Bertolotto, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2782 · Cited by 536 · see citing works

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523 · see citing works

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?

Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J.-F., & Bost, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1186 · Cited by 493 · see citing works

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466 · see citing works

AMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis

Meley, D., Bauvy, C., Houben-Weerts, J. H. P. M., Dubbelhuis, P. F., Helmond, M. T. J., Codogno, P., & Meijer, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605488200 · Cited by 461 · see citing works

Let-7 expression defines two differentiation stages of cancer

Shell, S. A., Park, S.-M., Radjabi, A. R., Schickel, R., Kistner, E. O., Jewell, D. A., Feig, C., Lengyel, E. R., & Peter, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704372104 · Cited by 458 · see citing works

Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden

Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412 · see citing works

Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression

Peter, M. E. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7907 · Cited by 404 · see citing works

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Liu, B., Fan, Z., Edgerton, S. M., Deng, X.-S., Alimova, I. N., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8814 · Cited by 392 · see citing works

Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence

Chicas, A., Wang, X., Zhang, C., McCurrach, M., Zhao, Z., Mert, O., Dickins, R. A., Narita, M., Zhang, M., & Lowe, S. W. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.023 · Cited by 388 · see citing works

Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

O’Shaughnessy, J., Kelloff, G. J., Gordon, G., Dannenberg, A. J., Hong, W. K., Fabian, C. J., Sigman, C. C., Bertagnolli, M. M., Stratton, S. P., Lam, S. C., et al. (2002) · PubMed · Cited by 381 · see citing works

Metformin: Taking away the candy for cancer?

Jalving, M., Gietema, J. A., Lefrandt, J. D., de Jong, S., Reyners, A. K. L., Gans, R. O. B., & de Vries, E. G. E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.012 · Cited by 377 · see citing works

Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST

Tsai, C., Chen, Y.-J., Yew, T., Chen, L., Wang, J., Chiu, C., & Hung, S. (2010) · Blood · doi:10.1182/blood-2010-05-287508 · Cited by 376 · see citing works

<i>BNIP3</i> Is an RB/E2F Target Gene Required for Hypoxia-Induced Autophagy

Tracy, K., Dibling, B. C., Spike, B. T., Knabb, J. R., Schumacker, P., & Macleod, K. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02246-06 · Cited by 369 · see citing works

Targeting Breast Cancer Stem Cells

Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 360 · see citing works

Using Autopsy Series To Estimate the Disease “Reservoir” for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?

Welch, H. G., & Black, W. C. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00014 · Cited by 347 · see citing works

Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion

Chen, J., Imanaka, N., Chen, J., & Griffin, J. D. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605486 · Cited by 346 · see citing works

Tailoring to RB: tumour suppressor status and therapeutic response

Knudsen, E. S., & Knudsen, K. E. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2401 · Cited by 345 · see citing works

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance

Wang, Z. P., Li, Y., Ahmad, A., Azmi, A. S., Kong, D., Banerjee, S., & Sarkar, F. H. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.07.001 · Cited by 342 · see citing works

Lysosomal Targeting of E-Cadherin: a Unique Mechanism for the Down-Regulation of Cell-Cell Adhesion during Epithelial to Mesenchymal Transitions

Palacios, F., Tushir, J. S., Fujita, Y., & D’Souza‐Schorey, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.389-402.2005 · Cited by 333 · see citing works

Does diabetes therapy influence the risk of cancer?

Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316 · see citing works

Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

Hosono, K., Endo, H., Takahashi, H., Sugiyama, M., Sakai, E., Uchiyama, T., Suzuki, K., Iida, H., Sakamoto, Y., Yoneda, K., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0186 · Cited by 311 · see citing works

Zeb1 links epithelial-mesenchymal transition and cellular senescence

Liu, Y., El‐Naggar, S., Darling, D. S., Higashi, Y., & Dean, D. C. (2008) · Development · doi:10.1242/dev.007047 · Cited by 304 · see citing works

TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development

Yang, M., & Wu, K.-J. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6324 · Cited by 295 · see citing works

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

Fillmore, C., Gupta, P. B., Rudnick, J., Caballero, S., Keller, P. J., Lander, E., & Kuperwasser, C. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1007863107 · Cited by 283 · see citing works

Oncogene-Induced Senescence: Putting the Brakes on Tumor Development

Braig, M., & Schmitt, C. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4006 · Cited by 274 · see citing works

4E-Binding Protein 1: A Key Molecular “Funnel Factor” in Human Cancer with Clinical Implications

Armengol, G., Rojo, F., Castellví, J., Iglesias, C., Cuatrecasas, M., Pons, B., Baselga, J. M., & y Cajal, S. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0881 · Cited by 272 · see citing works

Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction

Elmore, L. W., Rehder, C. W., Di, X. M., McChesney, P. A., Jackson‐Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271 · see citing works

Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM

Wang, Y.-Z., Yu, Y., Tsuyada, A., Ren, X., Wu, X., Stubblefield, K., Rankin-Gee, E., & Wang, S. E. (2010) · Oncogene · doi:10.1038/onc.2010.531 · Cited by 263 · see citing works

Trends in development and approval times for new therapeutics in the United States

Reichert, J. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1178 · Cited by 261 · see citing works

Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization

Qadir, M. A., Kwok, B., Dragowska, W. H., To, K.-C., Le, D., Bally, M. B., & Gorski, S. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9873-4 · Cited by 260 · see citing works

Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab

Magnifico, A., Albano, L., Campaner, S., Delia, D., Castiglioni, F., Gasparini, P., Sozzi, G., Fontanella, E., Ménard, S., & Tagliabue, E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1327 · Cited by 252 · see citing works

Cdk2 suppresses cellular senescence induced by the c-myc oncogene

Campaner, S., Doni, M., Hydbring, P., Verrecchia, A., Bianchi, L., Sardella, D., Schleker, T., Perna, D., Tronnersjö, S., Murga, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb2004 · Cited by 251 · see citing works

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7499 · Cited by 250 · cited 2× · see citing works

Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1

Zhuang, Y., & Miskimins, W. K. (2008) · Journal of Molecular Signaling · doi:10.1186/1750-2187-3-18 · Cited by 247 · see citing works

Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab

Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006251 · Cited by 245 · see citing works

The expression profile of microRNAs in mouse embryos

Mineno, J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl096 · Cited by 243 · see citing works

Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2

Park, S.-M., Shell, S. A., Radjabi, A. R., Schickel, R., Feig, C., Boyerinas, B., Dinulescu, D. M., Lengyel, E. R., & Peter, M. E. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4845 · Cited by 242 · see citing works

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

Creighton, C. J., Chang, J. C., & Rosen, J. M. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9173-1 · Cited by 242 · see citing works

Metformin and Other Biguanides in Oncology: Advancing the Research Agenda

Pollak, M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0175 · Cited by 240 · cited 4× · see citing works

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

Algire, C., Amrein, L., Zakikhani, M., Panasci, L., & Pollak, M. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0252 · Cited by 234 · see citing works

The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells

Taylor, M. A., Parvani, J. G., & Schiemann, W. P. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9181-1 · Cited by 231 · see citing works

Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer

Goodwin, P. J., Pritchard, K. I., Ennis, M., Clemons, M. J., Graham, M., & Fantus, I. G. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.060 · Cited by 228 · see citing works

A role for microRNAs in maintenance of mouse mammary epithelial progenitor cellsPreprint

Ibarra, I., Erlich, Y., Muthuswamy, S. K., Sachidanandam, R., & Hannon, G. J. (2007) · Genes & Development · doi:10.1101/gad.1616307 · Cited by 218 · see citing works

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis

Cufí, S., Vazquez-Martin, A., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.22.14048 · Cited by 216 · see citing works

Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast Tumors

Gauthier, M. L., Berman, H. K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y. Y., Kerlikowske, K., & Tlsty, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.017 · Cited by 214 · see citing works

Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena

Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10994 · Cited by 211 · see citing works

Metformin: A Therapeutic Opportunity in Breast Cancer

Gonzalez-Angulo, A. M., & Meric‐Bernstam, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1805 · Cited by 209 · see citing works

Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status

Vázquez‐Martín, A., Oliveras‐Ferraros, C., Cufí, S., Barco, S. D., Martı́n-Castillo, B., & Menéndez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13131 · Cited by 205 · see citing works

14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition

Lü, J., Guo, H., Treekitkarnmongkol, W., Li, P., Zhang, J., Shi, B., Ling, C., Zhou, X., Chen, T., Chiao, P. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.010 · Cited by 193 · see citing works

A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance

Samaddar, J. S., Gaddy, V. T., Duplantier, J., Thandavan, S. P., Shah, M. A., Smith, M. J., Browning, D. D., Rawson, J., Smith, S. B., Barrett, J. T., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0447 · Cited by 189 · see citing works

Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo

Algire, C., Amrein, L., Bazile, M., David, S., Zakikhani, M., & Pollak, M. (2010) · Oncogene · doi:10.1038/onc.2010.483 · Cited by 181 · see citing works

The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells

Vázquez‐Martín, A., Oliveras‐Ferraros, C., Barco, S. D., Martı́n-Castillo, B., & Menéndez, J. A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0924-x · Cited by 180 · see citing works

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

Goodwin, P. J., Stambolic, V., Lemieux, J., Chen, B. E., Parulekar, W. R., Gelmon, K. A., Hershman, D. L., Hobday, T. J., Ligibel, J. A., Mayer, I. A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1224-1 · Cited by 177 · see citing works

TWISTing an embryonic transcription factor into an oncoprotein

Ansieau, S., Morel, A.-P., Hinkal, G. W., Bastid, J., & Puisieux, A. (2010) · Oncogene · doi:10.1038/onc.2010.92 · Cited by 169 · see citing works

Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer

Lundgren, K., Nordenskjöld, B. A., & Landberg, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605369 · Cited by 169 · see citing works

Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice

Alli, P. M., Pinn, M. L., Jaffee, E. M., McFadden, J. M., & Kuhajda, F. P. (2004) · Oncogene · doi:10.1038/sj.onc.1208174 · Cited by 167 · see citing works

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

Ohashi, S., Natsuizaka, M., Wong, G. S., Michaylira, C. Z., Grugan, K. D., Stairs, D. B., Kalabis, J., Vega, M. E., Kalman, R. A., Nakagawa, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4614 · Cited by 164 · see citing works

Raf plus TGFβ-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin

Janda, E., Nevolo, M. T., Lehmann, K., Downward, J., Beug, H., & Grieco, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209701 · Cited by 161 · see citing works

RB and c-Myc Activate Expression of the E-Cadherin Gene in Epithelial Cells through Interaction with Transcription Factor AP-2

Batsché, É., Muchardt, C., Behrens, J., Hurst, H. C., & Crémisi, C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3647 · Cited by 161 · see citing works

Classification of ductal carcinoma in situ by gene expression profiling

Hannemann, J., Velds, A., Halfwerk, J. B. G., Kreike, B., Peterse, J. L., & van de Vijver, M. J. (2006) · Breast Cancer Research · doi:10.1186/bcr1613 · Cited by 160 · see citing works

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation

Louie, E., Nik, S., Chen, J., Schmidt, M. M., Song, B., Pacson, C., Chen, X. F., Park, S.-H. E., Ju, J., & Chen, E. I. (2010) · Breast Cancer Research · doi:10.1186/bcr2773 · Cited by 156 · see citing works

Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition

Arima, Y., Inoue, Y., Shibata, T., Hayashi, H., Nagano, O., Saya, H., & Taya, Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5680 · Cited by 151 · see citing works

Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status

Jiang, Z., Deng, T., Jones, R. A., Li, H., Herschkowitz, J. I., Liu, J. C., Weigman, V., Tsao, M., Lane, T. F., Perou, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41490 · Cited by 148 · see citing works

Inhibition of Hepatocytic Autophagy by Adenosine, Aminoimidazole-4-carboxamide Riboside, and N 6-Mercaptopurine Riboside

Samari, H. R., & Seglen, P. O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23758 · Cited by 145 · see citing works

Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival

Espina, V. A., Mariani, B. D., Gallagher, R. I., Tran, K., Banks, S., Wiedemann, J., Huryk, H., Mueller, C., Adamo, L., Deng, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010240 · Cited by 144 · see citing works

Metformin for aging and cancer prevention

Anisimov, V. N. (2010) · Aging · doi:10.18632/aging.100230 · Cited by 140 · see citing works

Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance

Schoenlein, P., Periyasamy‐Thandavan, S., Samaddar, J. S., Jackson, W., & Barrett, J. (2009) · Autophagy · doi:10.4161/auto.5.3.7784 · Cited by 138 · see citing works

Mimicry of a Cellular Low Energy Status Blocks Tumor Cell Anabolism and Suppresses the Malignant Phenotype

Swinnen, J. V., Beckers, A., Brusselmans, K., Organe, S., Segers, J., Timmermans, L., Vanderhoydonc, F., Deboel, L., Derua, R., Waelkens, E., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3025 · Cited by 133 · see citing works

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

Muggerud, A. A., Hallett, M. T., Johnsen, H., Sahlberg, K. K., Zhou, W., Tahmasebpoor, S., Amini, R., Botling, J., Børresen‐Dale, A., Sørlie, T., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.007 · Cited by 132 · see citing works

Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?

Tan, A. R., Alexe, G., & Reiß, M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0184-1 · Cited by 124 · see citing works

Twist and p53 reciprocally regulate target genes via direct interaction

Shiota, M., Izumi, H., Onitsuka, T., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Takahashi, M., Naito, S., & Kohno, K. (2008) · Oncogene · doi:10.1038/onc.2008.176 · Cited by 124 · see citing works

Going malignant: the hypoxia‐cancer connection in the prostate

Hochachka, P. W., Rupert, J. L., Goldenberg, L., Gleave, M. E., & Kozłowski, P. (2002) · BioEssays · doi:10.1002/bies.10131 · Cited by 117 · see citing works

The RB-E2F1 Pathway Regulates Autophagy

Jiang, H., Martı́n, V., Gomez‐Manzano, C., Johnson, D. G., Alonso, M. M., White, E. J., Xu, J., McDonnell, T. J., Shinojima, N., & Fueyo-Margareto, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1604 · Cited by 117 · see citing works

The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells

Sahra, I. B., Tanti, J., & Bost, F. (2010) · Autophagy · doi:10.4161/auto.6.5.12434 · Cited by 116 · see citing works

RB in Breast Cancer: The Crossroads of Tumorigenesis and Treatment

Bosco, E. E., & Knudsen, E. S. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3988 · Cited by 115 · see citing works

Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a

Oliveras‐Ferraros, C., Cufí, S., Vázquez‐Martín, A., Torres-Garcia, V. Z., Barco, S. D., Martı́n-Castillo, B., & Menéndez, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15210 · Cited by 109 · see citing works

Tumorigenesis: Twist1 links EMT to self-renewal

Martín, A. L., & Cano, A. (2010) · Nature Cell Biology · doi:10.1038/ncb1010-924 · Cited by 106 · see citing works

What is the malignant nature of human ductal carcinoma in situ?

Espina, V. A., & Liotta, L. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2950 · Cited by 106 · see citing works

Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis

Horwitz, K. B., & Sartorius, C. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0938 · Cited by 105 · see citing works

Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths

Smit, M. A., & Peeper, D. S. (2010) · Aging · doi:10.18632/aging.100209 · Cited by 104 · see citing works

Twisted epithelial–mesenchymal transition blocks senescence

Weinberg, R. A. (2008) · Nature Cell Biology · doi:10.1038/ncb0908-1021 · Cited by 94 · see citing works

Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype

Liu, Y., Clem, B. F., Zuba‐Surma, E. K., El‐Naggar, S., Telang, S., Jenson, A. B., Wang, Y., Shao, H., Ratajczak, M. Z., Chesney, J. A., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.02.015 · Cited by 92 · see citing works

Regulation of Cellular Senescence and p16 Expression by Id1 and E47 Proteins in Human Diploid Fibroblast

Zheng, W., Wang, H., Xue, L., Zhang, Z., & Tong, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400365200 · Cited by 88 · see citing works

Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway

Rice, S., Pellatt, L. J., Ramanathan, K., Whitehead, S. A., & Mason, H. D. (2009) · Endocrinology · doi:10.1210/en.2009-0540 · Cited by 88 · see citing works

Connecting autophagy to senescence in pathophysiology

Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 86 · see citing works

Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer

Lu, S. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh278 · Cited by 85 · see citing works

Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her‐2/neu (erbB‐2) oncogene‐induced malignant transformation

Menéndez, J. A., Mehmi, I., Verma, V. A., Teng, P. K., & Lupu, R. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20054 · Cited by 84 · see citing works

Defining the E-Cadherin Repressor Interactome in Epithelial-Mesenchymal Transition: The PMC42 Model as a Case Study

Hugo, H. J., Kokkinos, M. I., Blick, T., Ackland, M. L., Thompson, E. W., & Newgreen, D. F. (2010) · Cells Tissues Organs · doi:10.1159/000320174 · Cited by 83 · see citing works

The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches

Lacerda, L., Pusztai, L., & Woodward, W. A. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.001 · Cited by 78 · see citing works

BRCA1 and acetyl‐CoA carboxylase: The metabolic syndrome of breast cancer

Brunet, J., Vázquez‐Martín, A., Colomer, R., Graña-Suárez, B., Martı́n-Castillo, B., & Menéndez, J. A. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20364 · Cited by 76 · see citing works

Deregulating EMT and Senescence: Double Impact by a Single Twist

Smit, M. A., & Peeper, D. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.012 · Cited by 70 · see citing works

Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: Relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2

Menendez (1992) · International Journal of Oncology · doi:10.3892/ijo_00000127 · Cited by 66 · see citing works

Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical–translational research experience at the Catalan Institute of Oncology

Martı́n-Castillo, B., Dorca, J., Vázquez‐Martín, A., Oliveras‐Ferraros, C., López‐Bonet, E., García, M., del Barco, S., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp494 · Cited by 63 · see citing works

Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells

Vázquez‐Martín, A., Oliveras‐Ferraros, C., Cufí, S., Martı́n-Castillo, B., & Menéndez, J. A. (2010) · Current Molecular Medicine · doi:10.2174/156652410792630625 · Cited by 57 · see citing works

Gerosuppressant Metformin: less is more

Menéndez, J. A., Cufí, S., Oliveras‐Ferraros, C., Vellón, L., Joven, J., & Vázquez‐Martín, A. (2011) · Aging · doi:10.18632/aging.100316 · Cited by 57 · see citing works

Increasing CD44+/CD24- tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis

Wang, K., Kao, A., Chang, C., Lee, J.-N., Hou, M., Long, C., Chen, H., & Tsai, E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-288 · Cited by 56 · see citing works

Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis

Sahla, M. E., Thézenas, S., Simony-Lafontaine, J., Kramar, A., Lavaill, R., Chalbos, D., & Rochefort, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22202 · Cited by 53 · see citing works

Modern Approach to Metabolic Rehabilitation of Cancer Patients: Biguanides (Phenformin and Metformin) and Beyond

Berstein, L. M. (2010) · Future Oncology · doi:10.2217/fon.10.87 · Cited by 50 · see citing works

A hypoxic twist in metastasis

Peinado, H., & Cano, A. (2008) · Nature Cell Biology · doi:10.1038/ncb0308-253 · Cited by 49 · see citing works

The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.

Vázquez‐Martín, A., Oliveras‐Ferraros, C., Cufí, S., Barco, S. D., Martı́n-Castillo, B., López‐Bonet, E., & Menéndez, J. A. (2011) · PubMed · Cited by 49 · see citing works

HER2 Silences Tumor Suppression in Breast Cancer Cells by Switching Expression of C/EBPβ Isoforms

Estape, A. A., Tarragona, M., Morales, M. L. G., Guiu, M., Nadal, C., Massagué, J., & Gomis, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0869 · Cited by 46 · see citing works

Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification

Negri, T., Tarantino, E., Orsenigo, M., Reid, J. F., Gariboldi, M., Zambetti, M., Pierotti, M. A., & Pilotti, S. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20798 · Cited by 45 · see citing works

Insulin analogues and cancer risk: cause for concern orcause célèbre?

Pollak, M., & Russell-Jones, D. L. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02354.x · Cited by 45 · see citing works

LKB1 and Mammalian Target of Rapamycin As Predictive Factors for the Anticancer Efficacy of Metformin

Memmott, R. M., & Dennis, P. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3963 · Cited by 44 · see citing works

Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development

Kelloff, G. J., & Sigman, C. C. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2154 · Cited by 32 · see citing works

A lower bar for senescence

Serrano, M. (2010) · Nature · doi:10.1038/464363a · Cited by 30 · see citing works

Normal Breast Stem Cells, Malignant Breast Stem Cells, and the Perinatal Origin of Breast Cancer

Savarese, T. M., Low, H. P., Baik, I., Strohsnitter, W. C., & Hsieh, C. (2006) · Stem Cell Reviews and Reports · doi:10.1007/s12015-006-0016-9 · Cited by 29 · see citing works

Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications

Stoll, B. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf059 · Cited by 27 · see citing works

Biological mechanisms in breast cancer invasiveness

Stoll, B. A. (2000) · European Journal of Cancer Prevention · doi:10.1097/00008469-200004000-00002 · Cited by 21 · see citing works

Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires

Zhuang, Y., & Miskimins, W. K. (2008) · Cited by 18 · see citing works

Direct and indirect effects of the pRb tumor suppressor on autophagy

Ciavarra, G., & Zacksenhaus, E. (2011) · Autophagy · doi:10.4161/auto.7.5.15056 · Cited by 16 · see citing works

Expression status of the autophagy‐regulatory gene ATG6/BECN1 in ERBB2‐positive breast carcinomas: Bypassing ERBB2‐induced oncogenic senescence to regulate the efficacy of ERBB2‐targeted therapies

Vázquez‐Martín, A., Cufí, S., Oliveras‐Ferraros, C., Martı́n-Castillo, B., Barco, S. D., López‐Bonet, E., & Menéndez, J. A. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20846 · Cited by 11 · see citing works

More patent protection for medicines with a new purpose

Morgan, G. (2010) · Nature · doi:10.1038/4651005b · Cited by 7 · see citing works

In Situ Carcinoma—Can We Predict which Patient Will Come Back with a Recurrence?

Simpson, P. T., Silva, L. D., & Lakhani, S. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.026 · Cited by 7 · see citing works

Opportunities and challenges of radiotherapy for treating cancer

Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784 · see citing works

Polypharmacology: drug discovery for the future

Reddy, A. S., & Zhang, S. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.74 · Cited by 486 · see citing works

Metformin: Multi-faceted protection against cancer

Barco, S. D., Vázquez‐Martín, A., Cufí, S., Oliveras‐Ferraros, C., Bosch‐Barrera, J., Joven, J., Martı́n-Castillo, B., & Menéndez, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.387 · Cited by 302 · see citing works

Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity

Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253 · see citing works

Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects

Pierotti, M. A., Berrino, F., Gariboldi, M., Melani, C. C., Mogavero, A., Negri, T., Pasanisi, P., & Pilotti, S. (2012) · Oncogene · doi:10.1038/onc.2012.181 · Cited by 251 · see citing works

The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells

Menéndez, J. A., Joven, J., Cufí, S., Corominas-Faja, B., Oliveras‐Ferraros, C., Cuyàs, E., Martı́n-Castillo, B., López‐Bonet, E., Alarcón, T., & Vázquez‐Martín, A. (2013) · Cell Cycle · doi:10.4161/cc.24479 · Cited by 158 · see citing works

Metabostemness: A New Cancer Hallmark

Menéndez, J. A., & Alarcón, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00262 · Cited by 115 · see citing works

Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells

Vázquez‐Martín, A., Vellón, L., Quirós, P. M., Cufí, S., de Galarreta, E. R., Oliveras‐Ferraros, C., Martín, Á. G., Martı́n-Castillo, B., López-Otı́n, C., & Menéndez, J. A. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19450 · Cited by 98 · see citing works

Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer

Menéndez, J. A., Cufí, S., Oliveras‐Ferraros, C., Martı́n-Castillo, B., Joven, J., Vellón, L., & Vázquez‐Martín, A. (2011) · Aging · doi:10.18632/aging.100407 · Cited by 84 · see citing works

Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting

Lu, B., Huang, X., Mo, J., & Zhao, W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00084 · Cited by 76 · see citing works

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment

Cufí, S., Vázquez‐Martín, A., Oliveras‐Ferraros, C., Corominas-Faja, B., Urruticoechea, A., Martı́n-Castillo, B., & Menéndez, J. A. (2012) · Oncotarget · doi:10.18632/oncotarget.742 · Cited by 75 · see citing works

Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring

Bhatia, S., Monkman, J. H., Toh, A. K. L., Nagaraj, S. H., & Thompson, E. W. (2017) · Biochemical Journal · doi:10.1042/bcj20160782 · Cited by 73 · see citing works

The nutritional phenome of EMT-induced cancer stem-like cells

Cuyàs, E., Corominas-Faja, B., & Menéndez, J. A. (2014) · Oncotarget · doi:10.18632/oncotarget.2147 · Cited by 69 · see citing works

MicroRNAs and cancer stem cells: Therapeutic approaches and future perspectives

Leal, J. A., & LLeonart, M. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.020 · Cited by 68 · see citing works

In Vitro Screening for Drug Repositioning

WILKINSON, G. F., & Pritchard, K. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114563024 · Cited by 66 · see citing works

Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis

Liu, Q., Yuan, W., Tong, D., Liu, G., Lan, W., Zhang, D., Xiao, H., Zhang, Y., Huang, Z., Yang, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8595 · Cited by 65 · see citing works

Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism

Csermely, P., Hódsági, J., Korcsmaros, T. D., Módos, D., Perez-Lopez, Á. R., Szalay, K. Z., Veres, D. V., Lenti, K., Wu, L., & Zhang, X.-S. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.004 · Cited by 62 · see citing works

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)

Reipas, K. M., Law, J. H., Couto, N., Islam, S., Li, Y. Y., Li, H., Cherkasov, A. R., Jung, K., Cheema, A. S., Jones, S. J. M., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.834 · Cited by 63 · see citing works

Multifunctional targets of dietary polyphenols in disease: A case for the chemokine network and energy metabolism

Joven, J., Rull, A., Rodríguez‐Gallego, E., Camps, J., Riera-Borrull, M., Hernández‐Aguilera, A., Martín-Paredero, V., Segura‐Carretero, A., Micol, V., Alonso‐Villaverde, C., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.004 · Cited by 61 · see citing works

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)

Diessner, J., Bruttel, V. S., Stein, R. G., Horn, E., Häusler, S. F., Dietl, J., Hönig, A., & Wischhusen, J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.115 · Cited by 61 · see citing works

Metformin lowers the threshold for stress-induced senescence: A role for the microRNA-200 family and miR-205

Cufí, S., Vázquez‐Martín, A., Oliveras‐Ferraros, C., Quirantes‐Piné, R., Segura‐Carretero, A., Micol, V., Joven, J., Bosch‐Barrera, J., Barco, S. D., Martı́n-Castillo, B., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19665 · Cited by 60 · see citing works

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell

Nishi, M., Akutsu, H., Kudoh, A., Kimura, H., Yamamoto, N., Umezawa, A., Lee, S. W., & Ryo, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2356 · Cited by 56 · see citing works

Basal/HER2 breast carcinomas

Martı́n-Castillo, B., Oliveras‐Ferraros, C., Vázquez‐Martín, A., Cufí, S., Moreno, J. M., Corominas-Faja, B., Urruticoechea, A., Martín, Á. G., López‐Bonet, E., & Menéndez, J. A. (2013) · Cell Cycle · doi:10.4161/cc.23274 · Cited by 53 · see citing works

Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations

Chan, M. M.-Y., Chen, R., & Fong, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.034 · Cited by 52 · see citing works

The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin

Kato, K., Iwama, H., Yamashita, T., Kobayashi, K., Fujihara, S., Fujimori, T., Kamada, H., Kobara, H., & Masaki, T. (2015) · Oncology Reports · doi:10.3892/or.2015.4496 · Cited by 43 · see citing works

The role of Runx2 in facilitating autophagy in metastatic breast cancer cells

Tandon, M., Othman, A. H., Ashok, V., Stein, G. S., & Pratap, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25916 · Cited by 41 · see citing works

Targeting pancreatic cancer stem cells for cancer therapy

Xia, J., Chen, C., Chen, Z., Miele, L., Sarkar, F. H., & Wang, Z. P. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.002 · Cited by 39 · see citing works

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

Rezaee, H., Pourkarim, F., Pourtaghi-anvarian, S., Entezari-Maleki, T., Asvadi-Kermani, T., & Nouri-vaskeh, M. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.705 · Cited by 31 · see citing works

Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24−/low) indicate poor prognosis in triple-negative breast cancer

Chang, S., Ou‐Yang, F., Tu, H., Lin, C., Huang, S., Kostoro, J., Hou, M., Chai, C., & Kwan, A. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.09.034 · Cited by 35 · see citing works

Targeting breast cancer initiating cells: Advances in breast cancer research and therapy

McCubrey, J. A., Davis, N. M., Abrams, S. L., Montalto, G., Cervello, M., Libra, M., Nicoletti, F., D’Assoro, A. B., Cocco, L., Martelli, A. M., et al. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.05.003 · Cited by 35 · see citing works

The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors

Fonseca, N. A., Cruz, A. F., Moura, V., Simões, S., & Moreira, J. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.016 · Cited by 35 · see citing works

Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology

Barrière, G., Tartary, M., & Rigaud, M. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313020018 · Cited by 35 · see citing works

Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin

Cazzaniga, M., & Bonanni, B. (2015) · BioMed Research International · doi:10.1155/2015/972193 · Cited by 32 · see citing works

Chemoquiescence for Ideal Cancer Treatment and Prevention: Where Are We Now?

Kangwan, N., Park, J., Kim, E., & Hahm, K. B. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.89 · Cited by 31 · see citing works

Chloroquine and Chloroquinoline Derivatives as Models for the Design of Modulators of Amyloid Peptide Precursor Metabolism

Melnyk, P., Vingtdeux, V., Burlet, S., Eddarkaoui, S., Grosjean, M., Larchanché, P.-E., Hochart, G., Sergheraert, C., Estrella, C., Barrier, M., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003013 · Cited by 30 · see citing works

Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy

Sanctis, J. B. D., Charris, J., Blanco, Z., Ramírez, H., Martinez, G. P., & Mijares, M. R. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220519102948 · Cited by 29 · see citing works

Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties

Cuyàs, E., Martı́n-Castillo, B., Corominas-Faja, B., Massaguer, A., Bosch‐Barrera, J., & Menéndez, J. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1044173 · Cited by 28 · see citing works

Energy Metabolism and Metabolic Sensors in Stem Cells: The Metabostem Crossroads of Aging and Cancer

Menéndez, J. A., & Joven, J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_10 · Cited by 27 · see citing works

Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer

Tuomela, J. M., Sandholm, J. A., Kauppila, J. H., Lehenkari, P. P., Harris, K. W., & Selander, K. S. (2013) · Oncology Letters · doi:10.3892/ol.2013.1602 · Cited by 25 · see citing works

Co‐targeting of lysosome and mitophagy in cancer stem cells with chloroquine analogues and antibiotics

Al‐Bari, M. A. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15879 · Cited by 23 · see citing works

One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin

Menéndez, J. A., & Joven, J. (2013) · Aging · doi:10.18632/aging.100523 · Cited by 22 · see citing works

Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers

Kim, Y.-S., Lee, H. J., Park, J. M., Han, Y.-M., Kangwan, N., Oh, J. Y., Lee, D. Y., & Hahm, K. B. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1356224 · Cited by 21 · see citing works

Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology

Czogalla, B., Kahaly, M., Mayr, D. C., Schmoeckel, E., Niesler, B., Hester, A., Zeder-Göß, C., Kolben, T., Burges, A., Mahner, S., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s210004 · Cited by 21 · see citing works

A sirtuin activator and an anti-inflammatory molecule—multifaceted roles of adjudin and its potential applications for aging-related diseases

Xia, W., & Geng, K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.020 · Cited by 19 · see citing works

The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs

Menéndez, J. A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710150327 · Cited by 16 · see citing works

Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy

Karadeniz, Z., Aynacıoğlu, A. Ş., Bılır, A., & Tuna, M. Y. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109420 · Cited by 13 · see citing works

Effect of vesicular encapsulation on in-vitro cytotoxicity of ciclopirox olamine

Shaikh, K. S., Pawar, A., Aphale, S., & Moghe, A. (2012) · International Journal of Phytomedicine · Cited by 11 · see citing works

New phenylaniline derivatives as modulators of amyloid protein precursor metabolism

Gay, M., Carato, P., Coevoet, M., Renault, N., Larchanché, P.-E., Barczyk, A., Yous, S., Buée, L., Sergeant, N., & Melnyk, P. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.03.016 · Cited by 11 · see citing works

Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19

Al‐Bari, M. A. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666200617133142 · Cited by 9 · see citing works

Genetic ablation or pharmacologic inhibition of autophagy mitigated NSAID-associated gastric damages

Ock, C. Y., Park, J., Han, Y., Jeong, M., Kim, M.-Y., Lee, H. J., & Hahm, K. B. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1491-3 · Cited by 10 · see citing works

Mitigated NSAID-induced apoptotic and autophagic cell death with Smad7 overexpression

Lee, H.-J., Park, J. M., & Hahm, K. B. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-69 · Cited by 7 · see citing works

Autophagy Modulation for Organelle-Targeting Therapy

Martins, W. K., & Baptista, M. S. (2016) · InTech eBooks · doi:10.5772/63976 · Cited by 7 · see citing works

Metabolic stress in infected cells may represent a therapeutic target for human immunodeficiency virus infection

Alonso‐Villaverde, C., Menéndez, J. A., & Joven, J. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.04.009 · Cited by 5 · see citing works

THE IMPACT OF INFLAMMATION AND DRUG INTERACTIONS ON COVID-19 PHARMACOTHERAPY. A MINI-REVIEW

Neamţu, M. (2022) · FARMACIA · doi:10.31925/farmacia.2022.5.2 · Cited by 4 · see citing works

Clinically Significant Drug Interaction Profiles of Chloroquine Analogues with Adverse Consequences and Risk Management

Al‐Bari, M. A. A., & Islam, M. A. (2015) · Journal of Scientific Research · doi:10.3329/jsr.v7i3.22845 · Cited by 4 · see citing works

Nanoparticles of 4,7‐dichloro‐2‐quinolinemethylacrylate‐based copolymers and their potential cytotoxic activity on human breast carcinoma cells

Valle, H., Palao‐Suay, R., Aguilar, M. R., Román, J. S., Becerra, J., Rivas, B. L., & Mangalaraja, R. V. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.47545 · Cited by 2 · see citing works

Seizing Cancer Completely Through Specific Ablating Cancer Stem Cell: The Royal Road to Chemoquiescence

Park, J. M., Kangwan, N., Kim, E. H., Chung, M. K., Han, Y., Kwon, S. H., Kwon, C., & Hahm, K. B. (2014) · Springer eBooks · doi:10.1007/978-3-319-12253-3_23 · Cited by 1 · see citing works

A systematic review on Drug Re-profiling/Re-Purposing

Sharma, B., & Yadav, D. K. (2022) · IARS International Research Journal · doi:10.51611/iars.irj.v12i02.2022.218 · Cited by 1 · see citing works

Hydroxychloroquine (HCQ) induces inhibition of Col-II and COMP expression in the chondrocytes

Li, T., Yang, G., Dong, C.-J., Li, B., & Zhang, L. (2016) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v11i2.24882 · Cited by 1 · see citing works

Basics of Polypharmacology

Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_1 · Cited by 1 · see citing works

The Characterization of the Novel Chloroquine Derivative VR23 for its Anticancer Properties

Pundir, S. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4368

Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d'un nou subtipus de càncer de mama (Basal/ErbB2+)

Oliveras‐Ferraros, C. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Novos sistemas de delivery, uso tecnológico e reposicionamento da cloroquina e hidroxicloroquina: Uma revisão integrativa

Oliveira, C. D. R., Pereira, J. C., Oliveira, L. V. D. C., & Carvalho, A. L. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16589

Efficacies of repurposing chloroquine analogues for the treatment of COVID-19: Facts and mythsPreprint

Al‐Bari, M. A. A. (2020) · doi:10.22541/au.158679942.29108396

Therapeutic potential of drug repurposing in reversing chemoresistance

Panwar, V., & -, A. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45717-3.00014-3

BindingDB Entry 50002642: New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.

BindingDB (2020) · UC San Diego · doi:10.7270/q2j38w7j

Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies

Fong, D., Christensen, C. T., & Chan, M. M.-Y. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892816666210208232251 · Cited by 20 · see citing works

Existing drugs and their application in drug discovery targeting cancer stem cells

Lv, J., & Shim, J. S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0628-1 · Cited by 28 · see citing works

Metformin suppresses self‐renewal and stemness of cancer stem cell models derived from pluripotent stem cells

Zahra, M. H., Afify, S. M., Hassan, G., Nawara, H. M., Kumon, K., Seno, A., & Seno, M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3661 · Cited by 13 · see citing works

Repurposing existing drugs for cancer stem cell-directed therapy

Glavan, T. M. (2026) · Cancer Plus · doi:10.36922/cp025450073

The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs

Menéndez, J. A. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710150327 · Cited by 16 · see citing works